Cyclopharm Limited (CYC) is engaged in manufacturing and selling of medical equipment and radiopharmaceuticals, including associated research and development and distribution of third-party products to the diagnostic imaging sector.

There are at least 3m cases of Pulmonary Embolism globally each year. The company sells Technegas generators to radiology departments diagnosing this condition, and, on a recurring basis, the raw material (TN-99) in the form of 50 dose Patient Administration Sets (PAS).

Want to see other interesting ASX Healthcare Shares stocks?